FXYD6 and cancer: It has been known that FXYD6 is frequently up-regulated in cancer cells such as cholangiocarcinoma and osteosarcoma [100], and this higher level of FXYD6 can be targeted by miR-372-3p in osteosarcoma, thereby inhibiting the growth and metastasis of cancer cells [68].